Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

Jarding, John, OD404 enrolled

Overview

The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration. Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

404

Conditions

Interventions

Active microcurrent therapyDEVICE

Non-invasive transpalpebral microcurrent therapy delivery to the upper and lower eyelids

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged at least 50 years with dry AMD in at least one eye Exclusion Criteria: * Eye diseases other than dry AMD * Implanted electrical devices * Seizure disorders

Outcomes

Primary Outcomes

Mean logMAR BCVA

Mean logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) following the last treatment

Time frame: Week 1

Secondary Outcomes

Proportion of improved, stable or worsened BCVA

Proportion of eyes with improved, stable or worsened BCVA, and BCVA with both eyes open

Time frame: Week 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.